Related Papers
Journal of the American College of Cardiology
Highlights of the 2007 Scientific Sessions of the European Society of Cardiology
2007 •
Anselm Gitt
Atrial Fibrillation and the Brain How Long We Should Use Oral Anticoagulants after Electrical Cardioversion ? Ablation of Ventricular Tachycardia Home Monitoring of ICD Patients in Estonia Arrhythmias in Patients with Congenital Heart Defect
2015 •
Galina Zemtsovskaja
s Cardiology DOI: 10.1159/000431110 9 or less shared microbiota patterns in the household during childhood and adolescence due to cohabitation. It is hypothesised that microbiota profile as well as dietary intake patterns may cluster within families. Recently it was discovered that there is also a specific serum biomarker, the pro-atherosclerotic metabolite, trimethylamine-N-oxide (TMAO) that is able to reflect the gut microbiome [3]. It could be possible to measure this biomarker using plasma samples from new or existing biobanks within for evaluation of the TMAO marker status of individual microbiota [4]. Interventions to change the microbiota have provided some promising results and been described as a potential treatment target for cardio-metabolic disease [5]. Such interventions should be based on the wider use of designed and tested functional food products as part of a healthy lifestyle in general.
European Journal of Preventive Cardiology
Poster Session 3
2018 •
E. Trendafilova
Obesity Surgery
Remission of Metabolic Syndrome: A Study of 140 Patients Six Months after Roux-en-Y Gastric Bypass
2008 •
Ethel Chehter
European Heart Journal: Acute Cardiovascular Care, vol. 2 no. 1 suppl 8
Study Of The Relationship Between Physical And Mental Chronic Diseases And Quality Of Life Of Patients With Chronic Heart Failure
2013 •
Marianna Mantzorou
Heart India
Management of Coronary Artery Disease in 2013: Recent Insights
2013 •
Dr.Akshyaya Pradhan
presenting with chest pain. The superiority of these new assays, particularly in the early phase of pain onset, was prospectively demonstrated. [2,3] The negative predictive value for MI with a single test on admission is 95% and by including a second sample within 3 h of presentation the sensitivity for MI approaches 100%. The waiting time in Emergency Department can be reduced with a rapid rule put protocol. The new ESC guidelines for the management of ACS in patients presenting without persistent ST-segment elevation, 2011 now recommend a rapid rule-out protocol (0 and 3 h) when highly sensitive troponin tests are available. [4] The guidelines also emphasize the role for prompt withdrawl of blood for troponins and recommend point-of-care tests for troponins should be implemented when a central laboratory cannot consistently provide test results within 60 min. Coronary computed tomography (CT) angiography Multidetector computed tomography (CT) is a promising technique for direct visualization of the coronary arteries. Owing to its high negative predictive value reported in various studies [5-7] CT angiography, can be useful to exclude ACS or other causes of chest pain. The ESC 2011 guidelines for non ST segment elevation myocardial infarction (NSTEMI) recommend Coronary CT angiography as an alternative to invasive angiography to exclude ACS when there is a low to intermediate likelihood of CAD and when troponins and ECG are inconclusive (Class IIa). In the CT-STAT trial, Goldstein et al. [8] randomly assigned patients with acute chest pain in the Emergency Department to Coronary computed tomography angiography (CCTA) and to single-positron emission computed tomography myocardial perfusion imaging (MPI). The CCTA strategy resulted in a 54% reduction in time to diagnosis compared with MPI (2.9 h vs. 6.3 h), and costs of care were 38% lower for the CCTA group. The two strategies showed no difference in freedom from major adverse cardiac events (MACE) at 6 months of follow-up.
Life
Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia
Anca Ouatu
Advances in the treatment of hemophilia have made the life expectancy of hemophiliacs similar to that of the general population. Physicians have begun to face age-related diseases not previously encountered in individuals with hemophilia. Treatment of acute myocardial infarction (AMI) is particularly challenging because the therapeutic strategies influence both the patient’s thrombotic and hemorrhagic risk. As progress has been made in the treatment of AMI over the last decade, we performed an in-depth analysis of the available literature, highlighting the latest advances in the therapy of AMI in hemophiliacs. It is generally accepted that after the optimal substitution therapy has been provided, patients with hemophilia should be treated in the same way as those in the general population. New-generation stents that allow short dual antiplatelet therapy and potent P2Y12 receptor inhibitors have begun to be successfully used. At a time when specific recommendations and relevant data ...
The Egyptian Heart Journal
Abstracts - SA Heart Congress 2019
2019 •
Heart Congress
Circulation. Cardiovascular interventions
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis
2017 •
Philippe Garot
The optimal revascularization strategy in patients with multivessel disease presenting with cardiogenic shock complicating ST-segment-elevation myocardial infarction remains unknown. Databases were searched from 1999 to October 2016. Studies comparing immediate/single-stage multivessel percutaneous coronary intervention (MV-PCI) versus culprit vessel-only PCI (CO-PCI) in patients with multivessel disease, ST-segment-elevation myocardial infarction, and cardiogenic shock were included. Primary end point was short-term (in-hospital or 30 days) mortality. Secondary end points included long-term mortality, cardiovascular death, reinfarction, and repeat revascularization. Safety end points were in-hospital stroke, renal failure, and major bleeding. The meta-analysis included 11 nonrandomized studies and 5850 patients (1157 MV-PCI and 4693 CO-PCI). There was no significant difference in short-term mortality with MV-PCI versus CO-PCI (odds ratio [OR], 1.08; 95% confidence interval [CI], 0....
Indian Heart Journal
The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
2018 •
mahmoud elrayes
